Kestra Advisory Services’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $504K | Sell |
1,665
-41
| -2% | -$12.4K | ﹤0.01% | 1950 |
|
|
2025
Q1 | $565K | Buy |
1,706
+1
| +0.1% | +$331 | ﹤0.01% | 1740 |
|
|
2024
Q4 | $526K | Sell |
1,705
-909
| -35% | -$280K | ﹤0.01% | 1835 |
|
|
2024
Q3 | $555K | Buy |
2,614
+145
| +6% | +$30.8K | ﹤0.01% | 1703 |
|
|
2024
Q2 | $692K | Sell |
2,469
-115
| -4% | -$32.2K | ﹤0.01% | 1555 |
|
|
2024
Q1 | $690K | Sell |
2,584
-1,020
| -28% | -$272K | ﹤0.01% | 1463 |
|
|
2023
Q4 | $834K | Sell |
3,604
-2
| -0.1% | -$463 | 0.01% | 1220 |
|
|
2023
Q3 | $527K | Buy |
3,606
+25
| +0.7% | +$3.65K | 0.01% | 1344 |
|
|
2023
Q2 | $827K | Buy |
3,581
+1,021
| +40% | +$236K | 0.01% | 1069 |
|
|
2023
Q1 | $620K | Buy |
2,560
+104
| +4% | +$25.2K | 0.01% | 1169 |
|
|
2022
Q4 | $713K | Buy |
+2,456
| New | +$713K | 0.01% | 1212 |
|